During a research study on a new
allergy medication, one of Dr. BaldwinÂs participants dies of
complications unrelated to the medication. Because the death is not
related to the study, Dr. Baldwin is not required to report it to the IRB.
The correct answer is:
Every death of a study participant should be reported to the IRB, whether or not it is related to the study.